Jason G D Gall
Affiliation: GenVec Inc
- Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery methodChad J Roy
Infectious Disease Aerobiology, Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70447, USA
Respir Res 12:153. 2011..Overall, aerosol delivery offers comparable protection to intramuscular injection, and represents an attractive vaccine delivery method for broad-based immunization campaigns...
- Characterization of human adenovirus 35 and derivation of complex vectorsDuncan McVey
Department of Research, GenVec, Inc, Gaithersburg, MD 20874, USA
Virol J 7:276. 2010..The structure of the viral genome and life cycle of Ad35 differs from the better characterized Ad5 and these differences require differences in the strategies for the generation of vectors for gene delivery...
- Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenesJason G D Gall
GenVec, Inc 65 West Watkins Mill Rd, Gaithersburg MD 20878, USA
Mol Biotechnol 35:263-73. 2007..The gene regulation system is a significant advancement for the development of adenovirus vectors for vaccine and other gene transfer applications...
- Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28Christoph A Kahl
GenVec, Inc, 65 West Watkins Mill Road, Gaithersburg, MD 20878, USA
Vaccine 28:5691-702. 2010..The seroprevalence of Ad28 was confirmed to be <10% in the United States. Together, this shows that a rare human serotype-based vector can elicit strong immune responses, which was not predicted by in vitro results...